300194 福安药业
已收盘 05-17 15:00:00
资讯
新帖
简况
福安药业:截止2024年5月10日,公司股东户数为42403户
证券之星 · 05-14
福安药业:截止2024年5月10日,公司股东户数为42403户
福安药业:天衡药业旧厂区已完成拆迁交付,天衡药业具体经营情况需根据市场和销售情况确定
证券之星 · 05-10
福安药业:天衡药业旧厂区已完成拆迁交付,天衡药业具体经营情况需根据市场和销售情况确定
福安药业:您的相同或相似问题已
证券之星 · 05-07
福安药业:您的相同或相似问题已
福安药业(300194.SZ):喷他佐辛注射液、咪达唑仑注射液获药品注册证书
智通财经 · 04-30
福安药业(300194.SZ):喷他佐辛注射液、咪达唑仑注射液获药品注册证书
福安药业(300194)4月26日主力资金净卖出434.98万元
证券之星 · 04-29
福安药业(300194)4月26日主力资金净卖出434.98万元
福安药业(300194)2024年一季报简析:营收净利润同比双双增长
证券之星 · 04-26
福安药业(300194)2024年一季报简析:营收净利润同比双双增长
图解福安药业一季报:第一季度单季净利润同比增42.40%
证券之星 · 04-25
图解福安药业一季报:第一季度单季净利润同比增42.40%
福安药业最新公告:2023年度净利润2.32亿元 拟10派0.5元
证券之星 · 04-24
福安药业最新公告:2023年度净利润2.32亿元 拟10派0.5元
福安药业(300194.SZ)发布2023年度业绩,净利润2.32亿元,增长13.32%
智通财经网 · 04-24
福安药业(300194.SZ)发布2023年度业绩,净利润2.32亿元,增长13.32%
福安药业:目前公司在售原料药包括拉氧头孢、头孢唑肟、头孢美唑钠等多个产品
证券之星 · 04-23
福安药业:目前公司在售原料药包括拉氧头孢、头孢唑肟、头孢美唑钠等多个产品
福安药业(300194.SZ):尼麦角林片获药品注册证书
智通财经网 · 04-07
福安药业(300194.SZ):尼麦角林片获药品注册证书
福安药业(300194.SZ):“注射用头孢哌酮钠舒巴坦钠”通过一致性评价
智通财经网 · 02-21
福安药业(300194.SZ):“注射用头孢哌酮钠舒巴坦钠”通过一致性评价
福安药业(300194.SZ):化学原料药伏立康唑上市申请获批准
智通财经网 · 02-01
福安药业(300194.SZ):化学原料药伏立康唑上市申请获批准
福安药业:子公司帕拉米韦原料药获得上市申请批准 有助于丰富其产品线
财华社 · 01-24
福安药业:子公司帕拉米韦原料药获得上市申请批准 有助于丰富其产品线
福安药业(300194.SZ):化学原料药帕拉米韦上市申请获批
智通财经网 · 01-24
福安药业(300194.SZ):化学原料药帕拉米韦上市申请获批
福安药业(300194.SZ)副总经理洪荣川因涉嫌污染环境案被公安局取保候审
智通财经网 · 01-11
福安药业(300194.SZ)副总经理洪荣川因涉嫌污染环境案被公安局取保候审
福安药业:子公司药品吡拉西坦片通过一致性评价 有助于提升产品市场竞争力
财华社 · 01-08
福安药业:子公司药品吡拉西坦片通过一致性评价 有助于提升产品市场竞争力
加载更多
公司概况
公司名称:
福安药业(集团)股份有限公司
所属行业:
医药制造业
上市日期:
2011-03-22
主营业务:
福安药业(集团)股份有限公司主要从事化学药品的研发、生产、销售。主要产品有抗生素类(包括原料药、制剂不同规格)、抗肿瘤类、特色专科药类等药物。
发行价格:
41.88
{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":4.23,"timestamp":1715929428000,"preClose":4.27,"halted":0,"volume":26564096,"delay":0,"floatShares":968000000,"shares":1190000000,"eps":0.2256,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.04,"latestTime":"05-17 15:00:00","open":4.25,"high":4.29,"low":4.18,"amount":112000000,"amplitude":0.0258,"askPrice":4.24,"askSize":2140,"bidPrice":4.23,"bidSize":409,"shortable":0,"etf":0,"ttmEps":0.2256,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":4.27,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":4.7,"lowLimit":3.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"pbRate":1.19,"roa":"--","roe":"2.91%","epsLYR":0.19,"committee":0.217417,"marketValue":5032000000,"floatMarketCap":4094000000,"peRate":18.75,"changeRate":-0.0094,"turnoverRate":0.0274,"status":1},"requestUrl":"/m/hq/s/300194","defaultTab":"news","newsList":[{"id":"2435593956","title":"福安药业:截止2024年5月10日,公司股东户数为42403户","url":"https://stock-news.laohu8.com/highlight/detail?id=2435593956","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435593956?lang=zh_cn&edition=full","pubTime":"2024-05-14 18:02","pubTimestamp":1715680960,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)05月14日在投资者关系平台上答复投资者关心的问题。投资者:请问截至2024年5月10日公司的股东数是多少?谢谢福安药业董秘:截止2024年5月10日,公司股东户数为42403户,谢谢!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400027240.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434833445","title":"福安药业:天衡药业旧厂区已完成拆迁交付,天衡药业具体经营情况需根据市场和销售情况确定","url":"https://stock-news.laohu8.com/highlight/detail?id=2434833445","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434833445?lang=zh_cn&edition=full","pubTime":"2024-05-10 17:03","pubTimestamp":1715331790,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业05月10日在投资者关系平台上答复投资者关心的问题。去年公告说年底竣工,投产后你销量额大概多少福安药业董秘:天衡药业旧厂区已完成拆迁交付,天衡药业具体经营情况需根据市场和销售情况确定,谢谢!福安药业董秘:您好,只楚药业2023年营业收入为2.85亿元,营业收入和净利润较2022年均有所下降,目前只楚药业经营状况总体保持平稳,谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000031650.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433220732","title":"福安药业:您的相同或相似问题已","url":"https://stock-news.laohu8.com/highlight/detail?id=2433220732","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433220732?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:04","pubTimestamp":1715076258,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业05月07日在投资者关系平台上答复投资者关心的问题。子公司只楚药业是不是已经有了合成生物方面的应用?请如实回答,谢谢福安药业董秘:目前该子公司尚未正式运营,公司主要业务为化学制药的研发生产、销售,谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700031026.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431125323","title":"福安药业(300194.SZ):喷他佐辛注射液、咪达唑仑注射液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2431125323","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431125323?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:06","pubTimestamp":1714475190,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业 公告,公司全资子公司福安药业集团庆余堂制药有限公司于近日收到国家药品监督管理局签发的药品注册证书,药品名称为:喷他佐辛注射液、咪达唑仑注射液。公告显示,喷他佐辛注射液适用于各种慢性剧痛,如癌性疼痛、创伤性疼痛、手术后疼痛,也可用于手术前或麻醉前给药,作为外科手术麻醉的辅助用药。咪达唑仑注射液适应症为:肌内或静脉注射用于术前镇静/抗焦虑/记忆缺失。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116424.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431046207","title":"福安药业(300194)4月26日主力资金净卖出434.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431046207","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431046207?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:22","pubTimestamp":1714353778,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月26日收盘,福安药业报收于3.92元,下跌2.49%,换手率6.72%,成交量65.02万手,成交额2.56亿元。近5日资金流向一览见下表:福安药业融资融券信息显示,融资方面,当日融资买入3532.46万元,融资偿还1581.42万元,融资净买入1951.04万元。福安药业主营业务:从事化学药品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900002477.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430826386","title":"福安药业(300194)2024年一季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2430826386","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430826386?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:21","pubTimestamp":1714083662,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期福安药业发布2024年一季报。根据财报显示,本报告期中福安药业营收净利润同比双双增长。截至本报告期末,公司营业总收入8.09亿元,同比上升17.13%,归母净利润1.23亿元,同比上升42.4%。营收分析方面,公司最新一期年度报表的现金流为正,经营性现金流和利润相匹配。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600013672.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430246906","title":"图解福安药业一季报:第一季度单季净利润同比增42.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430246906","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430246906?lang=zh_cn&edition=full","pubTime":"2024-04-25 01:30","pubTimestamp":1713979851,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业2024年一季报显示,公司主营收入8.09亿元,同比上升17.13%;归母净利润1.23亿元,同比上升42.4%;扣非净利润1.17亿元,同比上升54.83%;负债率28.89%,投资收益2540.87万元,财务费用-75.62万元,毛利率51.03%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500002158.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429034480","title":"福安药业最新公告:2023年度净利润2.32亿元 拟10派0.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429034480","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429034480?lang=zh_cn&edition=full","pubTime":"2024-04-24 17:49","pubTimestamp":1713952183,"startTime":"0","endTime":"0","summary":"福安药业公布2023年年度报告,报告期营业收入26.48亿元,同比增长9.33%;归属于上市公司股东的净利润2.32亿元,同比增长13.32%;基本每股收益0.19元;拟向全体股东每10股派发现金红利0.5元(含税)。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400037759.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429482685","title":"福安药业(300194.SZ)发布2023年度业绩,净利润2.32亿元,增长13.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429482685","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429482685?lang=zh_cn&edition=full","pubTime":"2024-04-24 17:09","pubTimestamp":1713949741,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)发布2023年年度报告,报告期内,公司实现营业收入26.48亿元,同比增长9.33%。实现归属于上市公司股东的净利润2.32亿元,同比增长13.32%。实现归属于上市公司股东的扣除非经常性损益的净利润1648.83万元,同比下降89.94%。基本每股收益为0.19元。拟向全体股东每10股派发现金红利0.5元(含税)。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108536.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429876164","title":"福安药业:目前公司在售原料药包括拉氧头孢、头孢唑肟、头孢美唑钠等多个产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2429876164","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429876164?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:04","pubTimestamp":1713866656,"startTime":"0","endTime":"0","summary":"福安药业董秘:公司近几年药品研发持续进入收获期,包括原料药上市申请、制剂一致性评价、药品注册申请等获批数量较多,今年1月到目前为止,公司已披露10份与药品研发获批的相关公告,2023年的获批情况公司也有临时公告,并在年报当中进行汇总披露,谢谢!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300035502.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425197692","title":"福安药业(300194.SZ):尼麦角林片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2425197692","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2425197692?lang=zh_cn&edition=full","pubTime":"2024-04-07 17:11","pubTimestamp":1712481060,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)公告,公司全资子公司福安药业集团庆余堂制药有限公司(简称“庆余堂”)于近日收到国家药品监督管理局签发的药品注册证书,药品名称为尼麦角林片。尼麦角林片适用于改善由于脑梗塞后遗症引起的意欲低下;也适用于血管性痴呆,尤其在早期治疗时对认知、记忆等有改善,并能减轻疾病严重程度。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-07/doc-inaqzcvu5149365.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-07/doc-inaqzcvu5149365.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413541809","title":"福安药业(300194.SZ):“注射用头孢哌酮钠舒巴坦钠”通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2413541809","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2413541809?lang=zh_cn&edition=full","pubTime":"2024-02-21 15:51","pubTimestamp":1708501860,"startTime":"0","endTime":"0","summary":"福安药业发布公告,公司全资子公司福安药业集团庆余堂制药有限公司于近日收到国家药品监督管理局签发的药品补充申请批准通知书,涉及药品:“注射用头孢哌酮钠舒巴坦钠”。根据国家药品监督管理局相关数据平台显示,截止目前,该药品已有17家通过或视同通过一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-21/doc-inaiuuia5838476.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-21/doc-inaiuuia5838476.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2408570832","title":"福安药业(300194.SZ):化学原料药伏立康唑上市申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2408570832","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2408570832?lang=zh_cn&edition=full","pubTime":"2024-02-01 16:09","pubTimestamp":1706774940,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)公告,公司全资子公司福安药业集团重庆博圣制药有限公司(简称“博圣制药”)于近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书。公告显示,伏立康唑是一种广谱的三唑类抗真菌药,适用于治疗成人和2岁及2岁以上儿童患者的真菌感染。主要用于进展性、可能威胁生命的真菌感染患者的治疗。预防接受异基因造血干细胞移植(HSCT)的高危患者的侵袭性真菌感染。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-01/doc-inafpmyy0540349.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-01/doc-inafpmyy0540349.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2405469907","title":"福安药业:子公司帕拉米韦原料药获得上市申请批准 有助于丰富其产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=2405469907","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2405469907?lang=zh_cn&edition=full","pubTime":"2024-01-24 14:40","pubTimestamp":1706078459,"startTime":"0","endTime":"0","summary":"福安药业(300194)公告称,全资子公司福安药业集团宁波天衡制药有限公司于近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书。原料药名称为帕拉米韦,经审查,本品符合仿制药审批的有关规定,批准生产本品。截至目前,帕拉米韦原料药获得上市申请批准的有7家企业(含天衡药业)。上述原料药产品获得上市批准将可以在国内上市制剂中使用,进一步丰富了子公司产品线。","market":"other","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65b0b22e53243c07837547d0","is_publish_highlight":false,"gpt_icon":0},{"id":"2405562924","title":"福安药业(300194.SZ):化学原料药帕拉米韦上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2405562924","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2405562924?lang=zh_cn&edition=full","pubTime":"2024-01-24 11:48","pubTimestamp":1706068080,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)发布公告,公司全资子公司福安药业集团宁波天衡制药有限公司(“天衡药业”)于近日收到国家药品监督管理局签发的化学原料药上市申请批准通知书,涉及原料药:“帕拉米韦”。据悉,帕拉米韦主要用于治疗甲型或乙型流行性感冒。截至目前,帕拉米韦原料药获得上市申请批准的有7家企业(含天衡药业)。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-24/doc-inaeqyrk6914132.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-24/doc-inaeqyrk6914132.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2402942130","title":"福安药业(300194.SZ)副总经理洪荣川因涉嫌污染环境案被公安局取保候审","url":"https://stock-news.laohu8.com/highlight/detail?id=2402942130","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2402942130?lang=zh_cn&edition=full","pubTime":"2024-01-11 20:23","pubTimestamp":1704975780,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)发布公告,公司于今日收到副总经理洪荣川通知,重庆市公安局江北区分局于2024年1月5日出具《取保候审决定书》,因涉嫌污染环境案侦查所需,重庆市公安局江北区分局决定对公司副总经理洪荣川取保候审,期限从2024年1月5日起算。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-11/doc-inaceezu2981959.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-11/doc-inaceezu2981959.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2401676649","title":"福安药业:子公司药品吡拉西坦片通过一致性评价 有助于提升产品市场竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2401676649","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2401676649?lang=zh_cn&edition=full","pubTime":"2024-01-08 10:40","pubTimestamp":1704681636,"startTime":"0","endTime":"0","summary":"福安药业(300194)公告称,全资子公司福安药业集团烟台只楚药业有限公司于近日收到国家药品监督管理局签发的药品补充申请批准通知书,药品名称为吡拉西坦片。根据国家药品监督管理局相关信息平台显示,目前该药品有5家企业(含只楚药业)通过一致性评价或视同通过一致性评价。上述药品通过一致性评价将进一步提升子公司产品的市场竞争力。","market":"other","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/659b61ef53243c0783754560","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","stockEarnings":[{"period":"1week","weight":-0.0186},{"period":"1month","weight":0.1621},{"period":"3month","weight":0.2225},{"period":"6month","weight":-0.0864},{"period":"1year","weight":0.0193},{"period":"ytd","weight":-0.0342}],"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","perCapita":"22825股","boardName":"医药制造业","registeredCapital":"118971万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":" 福安药业(集团)股份有限公司主要从事化学药品的研发、生产、销售。主要产品有抗生素类(包括原料药、制剂不同规格)、抗肿瘤类、特色专科药类等药物。","serverTime":1716114600689,"listedPrice":41.88,"stockholders":"42403人(较上一季度增加0.05%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}